---
layout: post
title: "Cell Therapies and Tissue-Based Products: A Public Workshop on Generating Scientific Evidence to Facilitate Development; Public Workshop; Request for Comments"
date: 2026-02-04 21:49:42 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2025-01200
original_published: 2025-01-17 00:00:00 +0000
significance: 8.00
---

# Cell Therapies and Tissue-Based Products: A Public Workshop on Generating Scientific Evidence to Facilitate Development; Public Workshop; Request for Comments

**Published:** February 04, 2026 21:49 UTC
**Source:** Federal Register
**Original Published:** January 17, 2025 00:00 UTC
**Document Number:** 2025-01200

## Summary

The Food and Drug Administration (FDA, the Agency, or we) is announcing the following virtual public workshop entitled "Cell Therapies and Tissue-Based Products: A Public Workshop on Generating Scientific Evidence to Facilitate Development." The purpose of this workshop is to discuss the current state of the science for development and testing of certain cellular therapies and tissue-based products. In particular, FDA is convening this public workshop with relevant stakeholders to discuss best practices on generating scientific data necessary to further facilitate the development of cellular therapies, including stem cell products.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2025/01/17/2025-01200/cell-therapies-and-tissue-based-products-a-public-workshop-on-generating-scientific-evidence-to)
- API: https://www.federalregister.gov/api/v1/documents/2025-01200

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
